Y85-88753-61955
2 vaccinations
12 coded responses
21 check-ins
12 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 871 / NM
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Moderna
-
2021-01-12
Registered in v-safe
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion — Feeling: Fair · Site: Pain · NauseaFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
-
2021-01-15
Survey response — day 7, dose 1MedDRA: Respiratory tract congestion — Feeling: Fair · Fatigue or tiredness, NauseaFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-22
-
2021-01-29
Survey response — day 21, dose 1MedDRA: Abnormal faeces, Decreased appetite, Nausea, Rash — Feeling: FairFree text: Digestion concerns. Not severe enough to see a health care provider, but very concerning to see abnormal feces. Other concerns involve a change in skin condition from clear to breakouts. Final concern is a lack of appetite and nausea.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Dose 2 — Moderna
-
2021-02-05
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Dehydration, Dry eye, Nasal congestion — Feeling: Poor · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Dehydrated. Dry eyes. Nasal congestion.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Dehydration, Nasal congestion — Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Nasal congestion. Dehydration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Survey response — days 1–6 daily, dose 2MedDRA: Dehydration, Nasal congestion — Feeling: Fair · Site: Pain, ItchingFree text: Nasal congestion and dehydration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Dehydration, Nasal congestion, Respiratory tract congestion — Feeling: Good · Site: Pain, Itching · Diarrhea, Rash, not including the immediate area around the injection siteFree text: Dehydration, nasal and chest congestion.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — days 1–6 daily, dose 2MedDRA: Dehydration, Nasal congestion — Feeling: Good · Site: Itching · Fatigue or tirednessFree text: Nasal congestion and dehydration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Dehydration, Nasal congestion — Feeling: GoodFree text: Dehydration and slight nasal congestion.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — day 7, dose 2MedDRA: Dehydration — Feeling: GoodFree text: dehydrationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
-
2021-02-26
Survey response — day 21, dose 2MedDRA: Rash — Feeling: GoodFree text: Mild skin rash on fore arms and biceps during the day and at end of the day, shortly before bedtime, the rash becomes slightly moderate. Appears to be similar to eczema symptoms. In addition, symptoms persist in dehydration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-05-07
-
2021-08-06
Survey response — 6 months, dose 2MedDRA: Rash — Feeling: GoodFree text: Reoccurring skin rash that flares up unexpectedly on one side of body above the waist or sometimes both sides.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-02-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-05 | Moderna |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Congestion
Release 2 — day 7, dose 1
Systemic reaction (other): Congestion
Release 3 — day 21, dose 1
Symptoms: Digestion concerns. Not severe enough to see a health care provider, but very concerning to see abnormal feces. Other concerns involve a change in skin condition from clear to breakouts. Final concern is a lack of appetite and nausea.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Dehydrated. Dry eyes. Nasal congestion.
Systemic reaction (other): Nasal congestion. Dehydration.
Systemic reaction (other): Nasal congestion and dehydration.
Systemic reaction (other): Dehydration, nasal and chest congestion.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Nasal congestion and dehydration.
Systemic reaction (other): Dehydration and slight nasal congestion.
Release 4 — day 7, dose 2
Systemic reaction (other): dehydration
Release 4 — day 21, dose 2
Symptoms: Mild skin rash on fore arms and biceps during the day and at end of the day, shortly before bedtime, the rash becomes slightly moderate. Appears to be similar to eczema symptoms. In addition, symptoms persist in dehydration.
Release 9 — 6 months, dose 2
Symptoms: Reoccurring skin rash that flares up unexpectedly on one side of body above the waist or sometimes both sides.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abnormal faeces | ✓ | ✓ | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SRO | Dehydration | ✓ | ✓ | ✓ |
| SRO | Dry eye | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release